Othman Laraki
About Othman Laraki
Othman Laraki is co-founder and CEO of Color Health. Earlier he was a product leader at Google, where he worked on performance infrastructure and client-side software, including the Chrome browser. Before that he ran server-side engineering at ACCESS Systems.
After Google he founded Mixer Labs, which Twitter acquired in 2009. At Twitter he was Vice President of Product, working on the company's first revenue products as the user base grew from 50 to 200 million. He co-founded Color in 2013 and still leads it.
He holds degrees in computer science and management from Stanford and MIT. Public bios list board roles at the American Cancer Society, Frontier Medicines and ESI Group.
Public bios describe him as a long-time investor and advisor to companies including Pinterest, AngelList, Slack and Instacart. Database counts of his investments differ. PitchBook lists 70 investments and Crunchbase lists 42 portfolio companies. Treat those figures as approximate.
Tracxn's partial record shows a Series A in Bluenote AI in December 2024 and a seed round in Exponential in October 2022.
Two AI rounds from June 2026 are on the Lounge deals desk. Laraki took part in Monogram's $40M seed round, led by DST Global and Lux Capital. Monogram makes an AI app that generates interactive visual interfaces in place of text replies.
He also joined Uncovr's $7M seed round, led by Index Ventures. Uncovr builds software that turns surgical video into operative reports and procedural codes, with a surgeon reviewing each output. He is named in that round as CEO of Color Health.
Bluenote AI (2024) also appears in his record. Separately, Color has described AI-powered cancer care work with OpenAI and Google Cloud.
His public record leans toward early-stage rounds in health technology, enterprise software and consumer AI. Tracxn lists Enterprise Applications and HealthTech among his top sectors, and the United States and Sweden among his top locations. The rounds he has joined are typically seed and Series A, usually alongside institutional leads.
We found no check size or stated investment criteria from Laraki himself, and one third-party figure was unverified, so none is given here.
- Monogram: AI app that generates visual, interactive interfaces; $40M seed, June 2026.
- Uncovr: surgical video AI for operative reports and coding; $7M seed, June 2026.
- Bluenote AI: Series A of $10M listed by Tracxn, December 2024.
- Exponential: $14M seed listed by Tracxn, October 2022.
- Pinterest, Slack, Instacart, AngelList: named in his public bio as companies he has invested in or advised, with no dates given.
- color.com/leadership
- mucker.com/team/othman-laraki
- crunchbase.com/person/othman-laraki
- pitchbook.com/profiles/investor/105967-00
- tracxn.com/d/people/othman-laraki/__Ss1jI0ERpWyxxdd2ZJFlRTZT2-Hjz69gF0
- thesaasnews.com/news/monogram-raises-40m-seed
- indexventures.com/perspectives/uncovr-raises-7-million-in-seed-funding
- thenextweb.com/news/uncovr-7m-seed-surgical-ai-index-ventures
Investing activity
Othman Laraki appears in 2 AI deals tracked by the Lounge deals desk, rounds totalling $40M. The rounds are mostly Seed, with a median round size of $40M. The most recent are Monogram (Seed, $40M, Jun 2026) and Uncovr (Seed, $7M, Jun 2026).
Othman Laraki most often invests alongside Charlie Songhurst, Lux Capital, DST Global and Inc., and the companies they back on Lounge are mostly in AI.
Deals
Frequently asked questions about Othman Laraki
Does Othman Laraki invest in AI startups?
Yes. He took part in the Monogram $40M seed and the Uncovr $7M seed, both in June 2026. Uncovr applies AI to surgical video, and Monogram is a consumer AI app.
What is Othman Laraki's check size?
He has not published a check size that we could confirm. Third-party databases disagree, so founders should ask him directly.
What stage does Othman Laraki invest in?
His documented rounds are mostly seed and Series A. Examples are Monogram and Uncovr (seed) and Bluenote AI (Series A).
Who is Othman Laraki?
He is the co-founder and CEO of Color Health. He previously co-founded Mixer Labs, which Twitter acquired, and was Twitter's Vice President of Product.
Does Othman Laraki prefer healthcare founders?
His operating background is in health, and Uncovr and Bluenote AI are health-related. His record also includes consumer and enterprise software, so health is not the only focus.
How can founders contact Othman Laraki?
His LinkedIn profile is linkedin.com/in/othmanlaraki, and his X handle is reported as @othman. We found no personal website.
Is Othman Laraki an angel investor?
Yes. Othman Laraki invests personally as an angel.
What AI companies has Othman Laraki invested in?
Othman Laraki's AI investments include Monogram and Uncovr. The 2 rounds on Lounge are listed on this page with amounts, dates and co-investors.
What stage does Othman Laraki invest at?
In the rounds tracked on Lounge, Othman Laraki has invested at Seed, with a median round of $40M.
Who does Othman Laraki co-invest with?
Othman Laraki's most frequent co-investors on Lounge are Charlie Songhurst (2 deals), Lux Capital (1 deal), DST Global (1 deal), Inc. (1 deal) and Conviction (1 deal).